Phase III trial of sunitinib (SU) in combination with capecitabine (C) versus C in previously treated advanced breast cancer (ABC)

被引：47

作者：

Crown, J.

Dieras, V.

Staroslawska, E.

Yardley, D. A.

Davidson, N.

Bachelot, T. D.

Tassell, V. R.

Huang, X.

Kern, K. A.

Romieu, G.

机构：

[1] Irish Clin Oncol Res Grp, Dublin, Ireland

[2] Inst Curie, Paris, France

[3] Ctr Onkol Ziemi Lubelskiej, Lublin, Poland

[4] Sarah Cannon Res Inst, Nashville, TN USA

[5] Tennessee Oncol, Nashville, TN USA

[6] Broomfield Hosp, Chelmsford, Essex, England

[7] Ctr Laon Barard, Lyon, France

[8] Pfizer Inc, La Jolla, CA USA

[9] CRCL Val dAurelle, Montpellier, France

来源：

关键词：

D O I：

10.1200/jco.2010.28.18_suppl.lba1011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA1011

引用

页数：1